Does Cirrhosis Regress in HCV Liver Transplant Recipients Achieving Sustained Virologic Response in the Era of Direct-Acting Antiviral Agents?

被引：0
|
作者：
Putra, J. [1 ]
Schiano, T. [2 ]
Fiel, M. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Pathol, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
150
引用
收藏
页码：261 / 261
页数：1
相关论文
共 50 条
  • [21] Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral Agents
    Cholankeril, George
    Li, Andrew A.
    March, Katherine L.
    Yoo, Eric R.
    Kim, Donghee
    Snyder, Heather
    Gonzalez, Stevan A.
    Younossi, Zobair M.
    Ahmed, Aijaz
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (03) : 452 - 453
  • [22] Impact of Sustained Virologic Response with Direct-Acting Antiviral Treatment on Mortality and Hepatocellular Carcinoma
    Backus, Lisa I.
    Belperio, Pamela S.
    Shahoumian, Troy A.
    Mole, Larry A.
    HEPATOLOGY, 2017, 66 : 46A - 46A
  • [23] IMPACT OF DIRECT-ACTING ANTIVIRAL AGENTS ON LIVER TRANSPLANT OUTCOMES AMONG BLACK RECIPIENTS IN THE UNITED STATES
    Ochoa-Allemant, Pedro
    Ezaz, Ghideon
    HEPATOLOGY, 2021, 74 : 915A - 915A
  • [24] LIVER CANCER Effect of HCV clearance with direct-acting antiviral agents on HCC
    Llovet, Josep M.
    Villanueva, Augusto
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2016, 13 (10) : 561 - +
  • [25] Prophylaxis of HCV reinfection and direct-acting antiviral agents during liver transplantation
    Tavio, Marcello
    Vivarelli, Marco
    Menzo, Stefano
    Gori, Andrea
    Grossi, Paolo Antonio
    Marigliano, Anna
    LIVER TRANSPLANTATION, 2015, 21 (10) : 1327 - 1329
  • [26] Direct-acting antiviral treatment for hepatitis C in liver transplant candidates and recipients
    Akamatsu, Nobuhisa
    Togashi, Junichi
    Hasegawa, Kiyoshi
    Kokudo, Norihiro
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S598 - S602
  • [27] Risk factors for liver-related mortality of patients with hepatitis C virus after sustained virologic response to direct-acting antiviral agents
    Hattori, Nobuhiro
    Ikeda, Hiroki
    Watanabe, Tsunamasa
    Satta, Yosuke
    Ehira, Takuya
    Suzuki, Tatsuya
    Kiyokawa, Hirofumi
    Nakahara, Kazunari
    Takahashi, Hideaki
    Matsunaga, Kotaro
    Matsumoto, Nobuyuki
    Yasuda, Hiroshi
    Suzuki, Michihiro
    Itoh, Fumio
    Tateishi, Keisuke
    JGH OPEN, 2022, 6 (10): : 685 - 691
  • [28] Impact of Sustained Viral Response With Direct-Acting Agents on Glycemic Control and Renal Function in Hepatitis C Liver Transplant Recipients
    Saab, Sammy
    Barnard, Abbey
    Challita, Youssef
    Adeniyi, Adetola
    Aziz, Antony
    Choi, Gina
    Durazo, Francisco A.
    El-Kabany, Mohamed M.
    Han, Steven-Huy B.
    Busuttil, Ronald W.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2018, 16 (04) : 419 - 424
  • [29] Histological assessment of the liver explant in transplanted hepatitis C virus patients achieving sustained virological response with direct-acting antiviral agents
    Putra, Juan
    Schiano, Thomas D.
    Fiel, M. Isabel
    HISTOPATHOLOGY, 2018, 72 (06) : 990 - 996
  • [30] Assessment of hepatic fibrosis, portal hemodynamic changes, and disease severity in patients with HCV-related liver cirrhosis after sustained virologic response to direct-acting antiviral drugs (DAAs)
    Hassan, Waleed Attia
    Kamel, Sherif I.
    Mahmoud, Ibrahim Abdel Naby
    Makhlouf, Nahed
    Moubark, Mahmoud
    Hassany, Sahar M.
    EGYPTIAN LIVER JOURNAL, 2023, 13 (01)
12345